{
  "ticker": "MNMD",
  "company_name": "Mind Medicine (MindMed) Inc.",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT05753605",
      "title": "My Experiences: Leveraging Digital Technologies to Better Understand Mental Health",
      "status": "COMPLETED",
      "phase": "",
      "condition": "Mental Health Symptoms, Wearables",
      "start_date": "2023-06-26",
      "completion_date": "2025-05-31",
      "enrollment": 0,
      "sponsor": "4YouandMe"
    },
    {
      "nct_id": "NCT05200936",
      "title": "Safety and Efficacy of Low Dose MM-120 for ADHD Proof of Concept Trial",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "ADHD, Attention Deficit Disorder",
      "start_date": "2021-12-17",
      "completion_date": "2023-12-04",
      "enrollment": 0,
      "sponsor": "Definium Therapeutics"
    },
    {
      "nct_id": "NCT05407064",
      "title": "A Dose-Finding Study of MM-120 (LSD D-Tartrate) for the Treatment of Anxiety Symptoms",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Anxiety Generalized",
      "start_date": "2022-08-24",
      "completion_date": "2023-11-27",
      "enrollment": 0,
      "sponsor": "Definium Therapeutics"
    },
    {
      "nct_id": "NCT06941844",
      "title": "A Phase 3 Trial of MM120 for Major Depressive Disorder (Emerge)",
      "status": "RECRUITING",
      "phase": "PHASE3",
      "condition": "Major Depressive Disorder",
      "start_date": "2025-04-14",
      "completion_date": "2027-05",
      "enrollment": 0,
      "sponsor": "Definium Therapeutics"
    },
    {
      "nct_id": "NCT06741228",
      "title": "A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Voyage)",
      "status": "RECRUITING",
      "phase": "PHASE3",
      "condition": "Generalized Anxiety Disorder",
      "start_date": "2024-12-11",
      "completion_date": "2026-11",
      "enrollment": 0,
      "sponsor": "Definium Therapeutics"
    },
    {
      "nct_id": "NCT07303907",
      "title": "A Phase 2A Trial of MM402 for Autism Spectrum Disorder",
      "status": "RECRUITING",
      "phase": "PHASE2",
      "condition": "Autism Spectrum Disorder, ASD",
      "start_date": "2025-12-03",
      "completion_date": "2027-08",
      "enrollment": 0,
      "sponsor": "Definium Therapeutics"
    },
    {
      "nct_id": "NCT04292197",
      "title": "A Study to Assess 18-Methoxycoronaridine (18-MC HCl) in Healthy Volunteers",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Addiction",
      "start_date": "2020-04-14",
      "completion_date": "2021-12-31",
      "enrollment": 0,
      "sponsor": "Definium Therapeutics"
    },
    {
      "nct_id": "NCT06809595",
      "title": "A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Panorama)",
      "status": "RECRUITING",
      "phase": "PHASE3",
      "condition": "Generalized Anxiety Disorder",
      "start_date": "2025-01-29",
      "completion_date": "2027-05",
      "enrollment": 0,
      "sponsor": "Definium Therapeutics"
    },
    {
      "nct_id": "NCT05948917",
      "title": "Mind-Body Skills Groups for Incarcerated Men and Women",
      "status": "COMPLETED",
      "phase": "NA",
      "condition": "Resilience",
      "start_date": "2023-09-05",
      "completion_date": "2025-06-19",
      "enrollment": 0,
      "sponsor": "The Center for Mind-Body Medicine"
    },
    {
      "nct_id": "NCT02671487",
      "title": "Mind-Body Skills Groups for Behavioral and Emotional Problems in War-Traumatized Male Adolescents in Gaza",
      "status": "COMPLETED",
      "phase": "NA",
      "condition": "Problem Behavior, Aggression, Posttraumatic Stress Disorder",
      "start_date": "2016-01",
      "completion_date": "2017-03",
      "enrollment": 0,
      "sponsor": "The Center for Mind-Body Medicine"
    }
  ],
  "summary": {
    "total_trials": 23,
    "by_phase": {
      "": 3,
      "PHASE2": 3,
      "PHASE3": 3,
      "PHASE1": 1,
      "NA": 13
    },
    "by_status": {
      "COMPLETED": 16,
      "RECRUITING": 5,
      "ENROLLING_BY_INVITATION": 1,
      "TERMINATED": 1
    },
    "active_trials": 6,
    "completed_trials": 16,
    "conditions": [
      "ADHD, Attention Deficit Disorder",
      "Addiction",
      "Anxiety",
      "Anxiety Generalized",
      "Atrial Fibrillation, Stress, Quality of Life, Anxiety, Depression, Hostility",
      "Autism Spectrum Disorder, ASD",
      "Depression, Depressive Disorder",
      "Generalized Anxiety Disorder",
      "Healthy",
      "Major Depression",
      "Major Depressive Disorder",
      "Mental Health Symptoms, Wearables",
      "Parkinson's Disease, Depression",
      "Post Traumatic Stress Disorder PTSD",
      "Posttraumatic Stress Disorder",
      "Problem Behavior, Aggression, Posttraumatic Stress Disorder",
      "Resilience",
      "Stress Disorders, Post Traumatic, Brain Injuries, Depressive Disorder, Anxiety Disorders, Anger",
      "Stress Disorders, Post-traumatic"
    ],
    "lead_stage": "phase_3"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:20:04.893525",
    "search_query": "Mind Medicine (MindMed) Inc.",
    "url": "https://clinicaltrials.gov/search?term=Mind+Medicine+(MindMed)+Inc."
  }
}